Cargando…

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis

Patients suffering from mental disorders are at high risk of developing cardiovascular diseases, leading to a reduction in life expectancy. Genetic variants can display greater influence on cardiometabolic features in psychiatric cohorts compared to the general population. The difference is possibly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjaarda, Jennifer, Delacrétaz, Aurélie, Dubath, Céline, Laaboub, Nermine, Piras, Marianna, Grosu, Claire, Vandenberghe, Frederik, Crettol, Séverine, Ansermot, Nicolas, Gamma, Franziska, Plessen, Kerstin Jessica, von Gunten, Armin, Conus, Philippe, Kutalik, Zoltan, Eap, Chin B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611564/ https://www.ncbi.nlm.nih.gov/pubmed/37173452 http://dx.doi.org/10.1038/s41380-023-02082-3

Ejemplares similares

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort
por: Laaboub, Nermine, et al.
Publicado: (2021)

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
por: Laaboub, Nermine, et al.
Publicado: (2022)

Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort
por: Schoretsanitis, Georgios, et al.
Publicado: (2022)

Effects of psychotropic switches on weight change: a prospective cohort study
por: Piras, M., et al.
Publicado: (2022)

DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study
por: Dubath, C., et al.
Publicado: (2022)

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
por: Delacrétaz, Aurélie, et al.
Publicado: (2018)

Metabolic disturbances are associated with psychiatric readmission: results from a Swiss psychiatric cohort
por: Laaboub, N., et al.
Publicado: (2022)

Is Clozapine-induced Weight Gain Dose-dependent? Results From a Prospective Cohort Study
por: Piras, Marianna, et al.
Publicado: (2023)

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort
por: Dubath, Céline, et al.
Publicado: (2021)

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples
por: Perry, Benjamin I., et al.
Publicado: (2022)

Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients
por: Delacrétaz, Aurélie, et al.
Publicado: (2019)

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication
por: Alameda, Luis, et al.
Publicado: (2020)

Addition of Aripiprazole to the Clozapine May Be Useful in Reducing Anxiety in Treatment-Resistant Schizophrenia
por: Chanachev, Aleksandar, et al.
Publicado: (2011)

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution
por: Lenski, Marie, et al.
Publicado: (2021)

F227. PSYCHOLOGICAL TRAUMA OCCURRING DURING ADOLESCENCE IS ASSOCIATED WITH AN INCREASED RISK OF GREATER WAIST CIRCUMFERENCE IN EARLY PSYCHOSIS PATIENTS INDEPENDENTLY OF MEDICATION
por: Alameda, Luis, et al.
Publicado: (2018)

Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity
por: Guinchat, Vincent, et al.
Publicado: (2022)

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression
por: Delacrétaz, Aurélie, et al.
Publicado: (2015)

Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?
por: Crettol, Séverine, et al.
Publicado: (2007)

Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients
por: Ansermot, Nicolas, et al.
Publicado: (2019)

Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs
por: Eap, Chin B.
Publicado: (2016)

Weight gain and metabolic disorders induced by psychotropic drugs: an appraisal of risk factors
por: Eap, C. B.
Publicado: (2023)

Clinical, genetic and environmental influences on weight gain and metabolic disorders induced by psychotropic drugs
por: Eap, C.
Publicado: (2022)

Partner choice, confounding and trait convergence all contribute to phenotypic partner similarity
por: Sjaarda, Jennifer, et al.
Publicado: (2023)

An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis
por: Perry, B., et al.
Publicado: (2022)

SWISS CENTENARIANS: PRELIMINARY FINDINGS FROM THE SWISS100 PHONE STUDY
por: Jopp, Daniela, et al.
Publicado: (2022)

bGWAS: an R package to perform Bayesian genome wide association studies
por: Mounier, Ninon, et al.
Publicado: (2020)

Polynomial Mendelian randomization reveals non-linear causal effects for obesity-related traits
por: Sulc, Jonathan, et al.
Publicado: (2022)

Simultaneous estimation of bi-directional causal effects and heritable confounding from GWAS summary statistics
por: Darrous, Liza, et al.
Publicado: (2021)

The Contribution of GWAS Loci in Familial Dyslipidemias
por: Ripatti, Pietari, et al.
Publicado: (2016)

Nosology and treatment of primary headache in a Swiss headache clinic
por: Kozak*, S., et al.
Publicado: (2005)

Deep resequencing identifies candidate functional genes in leprosy GWAS loci
por: Fava, Vinicius M., et al.
Publicado: (2021)

Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations
por: Saigi-Morgui, Núria, et al.
Publicado: (2016)

GWAS of human bitter taste perception identifies new loci and reveals additional complexity of bitter taste genetics
por: Ledda, Mirko, et al.
Publicado: (2014)

Quantifying Missing Heritability at Known GWAS Loci
por: Gusev, Alexander, et al.
Publicado: (2013)

GWAS reveals loci associated with velopharyngeal dysfunction
por: Chernus, Jonathan, et al.
Publicado: (2018)

Functional screens refine height GWAS loci
por: Ackert-Bicknell, Cheryl L.
Publicado: (2023)

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
por: Böger, Carsten A., et al.
Publicado: (2011)

Identifying loci with breeding potential across temperate and tropical adaptation via EigenGWAS and EnvGWAS
por: Li, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9b79n8phgjb5dkmtqinajda4hk